Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule - PubMed (original) (raw)
Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule
J S McDougal et al. Science. 1986.
Abstract
Human T-lymphotropic virus type III (HTLV-III) or lymphadenopathy-associated virus (LAV) is tropic for human T cells with the helper-inducer phenotype, as defined by reactivity with monoclonal antibodies specific for the T4 molecule. Treatment of T4+ T cells with monoclonal antibodies to T4 antigen blocks HTLV-III/LAV binding, syncytia formation, and infectivity. Thus, it has been inferred that the T4 molecule itself is a virus receptor. In the present studies, the surfaces of T4+ T cells were labeled radioactively, and then the cells were exposed to virus. After the cells were lysed, HTLV-III/LAV antibodies were found to precipitate a surface protein with a molecular weight of 58,000 (58K). By blocking and absorption experiments, this 58K protein was identified as the T4 molecule. No cell-surface structures other than the T4 molecule were involved in the antibody-antigen complex formation. Two monoclonal antibodies, each reactive with a separate epitope of the T4 molecule, were tested for their binding capacities in the presence of HTLV-III/LAV. When HTLV-III/LAV was bound to T4+ T cells, the virus blocked the binding of one of the monoclonal antibodies, T4A (OKT4A), but not of the other, T4 (OKT4). When HTLV-III/LAV was internally radiolabeled and bound to T4+ T cells which were then lysed, a viral glycoprotein of 110K (gp110) coprecipitated with the T4 molecule. The binding of gp110 to the T4 molecule may thus be a major factor in HTLV-III/LAV tropism and may prove useful in developing therapeutic or preventive measures for the acquired immune deficiency syndrome.
Similar articles
- Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen.
McDougal JS, Mawle A, Cort SP, Nicholson JK, Cross GD, Scheppler-Campbell JA, Hicks D, Sligh J. McDougal JS, et al. J Immunol. 1985 Nov;135(5):3151-62. J Immunol. 1985. PMID: 2995487 - In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV).
Nicholson JK, Cross GD, Callaway CS, McDougal JS. Nicholson JK, et al. J Immunol. 1986 Jul 1;137(1):323-9. J Immunol. 1986. PMID: 3011909 - T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV.
Klatzmann D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend T, Gluckman JC, Montagnier L. Klatzmann D, et al. Nature. 1984 Dec 20-1985 Jan 2;312(5996):767-8. doi: 10.1038/312767a0. Nature. 1984. PMID: 6083454 - Immunopathogenesis of the acquired immunodeficiency syndrome.
Bowen DL, Lane HC, Fauci AS. Bowen DL, et al. Ann Intern Med. 1985 Nov;103(5):704-9. doi: 10.7326/0003-4819-103-5-704. Ann Intern Med. 1985. PMID: 2996403 Review. - Lymphadenopathy associated virus and its etiological role in AIDS.
Montagnier L, Chermann JC, Barré-Sinoussi F, Klatzmann D, Wain-Hobson S, Alizon M, Clavel F, Brun-Vezinet F, Vilmer E, Rouzioux C, et al. Montagnier L, et al. Princess Takamatsu Symp. 1984;15:319-31. Princess Takamatsu Symp. 1984. PMID: 6100650 Review.
Cited by
- Broadly neutralizing antibodies targeted to mucin-type carbohydrate epitopes of human immunodeficiency virus.
Hansen JE, Nielsen C, Arendrup M, Olofsson S, Mathiesen L, Nielsen JO, Clausen H. Hansen JE, et al. J Virol. 1991 Dec;65(12):6461-7. doi: 10.1128/JVI.65.12.6461-6467.1991. J Virol. 1991. PMID: 1719230 Free PMC article. - Loss of CD4 membrane expression and CD4 mRNA during acute human immunodeficiency virus replication.
Salmon P, Olivier R, Riviere Y, Brisson E, Gluckman JC, Kieny MP, Montagnier L, Klatzmann D. Salmon P, et al. J Exp Med. 1988 Dec 1;168(6):1953-69. doi: 10.1084/jem.168.6.1953. J Exp Med. 1988. PMID: 3264318 Free PMC article. - Biological significance of the antibody response to HIV antigens expressed on the cell surface.
Goudsmit J, Ljunggren K, Smit L, Jondal M, Fenyö EM. Goudsmit J, et al. Arch Virol. 1988;103(3-4):189-206. doi: 10.1007/BF01311092. Arch Virol. 1988. PMID: 3265052 - Mapping genetic determinants for human immunodeficiency virus type 1 resistance to soluble CD4.
O'Brien WA, Chen IS, Ho DD, Daar ES. O'Brien WA, et al. J Virol. 1992 May;66(5):3125-30. doi: 10.1128/JVI.66.5.3125-3130.1992. J Virol. 1992. PMID: 1373203 Free PMC article. - Current issues in developing a strategy for dealing with the acquired immunodeficiency syndrome.
Fauci AS. Fauci AS. Proc Natl Acad Sci U S A. 1986 Dec;83(24):9278-83. doi: 10.1073/pnas.83.24.9278. Proc Natl Acad Sci U S A. 1986. PMID: 3467307 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources